Baird Financial Group Inc. Has $16.70 Million Position in Cardinal Health, Inc. $CAH

Baird Financial Group Inc. grew its stake in Cardinal Health, Inc. (NYSE:CAH) by 107.2% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 99,393 shares of the company’s stock after purchasing an additional 51,416 shares during the quarter. Baird Financial Group Inc.’s holdings in Cardinal Health were worth $16,698,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also modified their holdings of the company. Norges Bank bought a new position in Cardinal Health in the 2nd quarter valued at about $584,420,000. Wellington Management Group LLP grew its position in shares of Cardinal Health by 1,666.7% in the first quarter. Wellington Management Group LLP now owns 2,384,192 shares of the company’s stock valued at $328,470,000 after purchasing an additional 2,249,241 shares during the last quarter. JPMorgan Chase & Co. grew its position in shares of Cardinal Health by 40.0% in the first quarter. JPMorgan Chase & Co. now owns 4,175,992 shares of the company’s stock valued at $575,327,000 after purchasing an additional 1,193,983 shares during the last quarter. Zurich Insurance Group Ltd FI increased its stake in shares of Cardinal Health by 4,935.9% during the first quarter. Zurich Insurance Group Ltd FI now owns 946,750 shares of the company’s stock worth $130,434,000 after purchasing an additional 927,950 shares during the period. Finally, Acadian Asset Management LLC lifted its holdings in Cardinal Health by 92.5% during the 2nd quarter. Acadian Asset Management LLC now owns 1,679,176 shares of the company’s stock worth $282,063,000 after purchasing an additional 807,063 shares during the last quarter. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Stock Down 0.1%

CAH opened at $198.93 on Friday. The stock has a market capitalization of $47.27 billion, a price-to-earnings ratio of 30.00, a P/E/G ratio of 1.45 and a beta of 0.63. Cardinal Health, Inc. has a twelve month low of $114.60 and a twelve month high of $214.93. The company has a 50-day simple moving average of $182.59 and a 200 day simple moving average of $165.13.

Cardinal Health (NYSE:CAH) last issued its earnings results on Thursday, October 30th. The company reported $2.55 EPS for the quarter, beating the consensus estimate of $2.22 by $0.33. Cardinal Health had a net margin of 0.68% and a negative return on equity of 84.37%. The company had revenue of $64.01 billion during the quarter, compared to analysts’ expectations of $59.41 billion. During the same period in the previous year, the company earned $1.88 EPS. The business’s revenue for the quarter was up 22.4% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 9.650-9.850 EPS. Sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Shareholders of record on Friday, January 2nd will be paid a dividend of $0.5107 per share. The ex-dividend date is Friday, January 2nd. This represents a $2.04 annualized dividend and a yield of 1.0%. Cardinal Health’s dividend payout ratio is presently 30.77%.

Analysts Set New Price Targets

A number of research analysts have commented on CAH shares. Evercore ISI upped their price objective on Cardinal Health from $190.00 to $220.00 and gave the company an “outperform” rating in a report on Friday, October 31st. Wall Street Zen upgraded shares of Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, November 8th. TD Cowen lifted their price objective on shares of Cardinal Health from $183.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 3rd. Robert W. Baird set a $232.00 price objective on shares of Cardinal Health in a report on Friday, October 31st. Finally, Deutsche Bank Aktiengesellschaft raised their target price on shares of Cardinal Health from $195.00 to $208.00 and gave the stock a “hold” rating in a report on Tuesday, November 18th. Twelve equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $206.57.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.